Literature DB >> 18510355

Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry.

Qiangwei Xia1, Dongmei Cheng, Duc M Duong, Marla Gearing, James J Lah, Allan I Levey, Junmin Peng.   

Abstract

Alzheimer's disease (AD), the most common form of dementia, is manifested in the brain by the aggregation of amyloid plaques and neurofibrillary tangles. The tangles are primarily composed of microtubule-associated protein tau that is aberrantly hyperphosphorylated, suggesting that deregulated phosphorylation may contribute to AD pathogenesis. However, systematic analysis of the phosphoproteome in AD brain tissues has not been reported. We used calcium phosphate precipitation to analyze an AD postmortem brain, followed by liquid chromatography-tandem mass spectrometry. The protein sample was first resolved by one-dimensional polyacrylamide gel electrophoresis and subjected to gel excision and in-gel digestion. Phosphopeptides in the resulting peptide mixtures were enriched in a single step of calcium phosphate precipitation, and then analyzed by the LC-MS/MS approach. After database search, stringent filtering, and manual validation of neutral loss in the MS/MS spectra, a total of 466 phosphorylation sites on 185 proteins including tau were identified. A majority of sites were not described previously. This study demonstrates the feasibility of combining calcium phosphate precipitation with mass spectrometry for phosphoproteome analysis of postmortem human brain tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510355      PMCID: PMC2663965          DOI: 10.1021/pr8000496

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  50 in total

1.  A systematic approach to the analysis of protein phosphorylation.

Authors:  H Zhou; J D Watts; R Aebersold
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

Review 2.  Large-scale database searching using tandem mass spectra: looking up the answer in the back of the book.

Authors:  Rovshan G Sadygov; Daniel Cociorva; John R Yates
Journal:  Nat Methods       Date:  2004-12       Impact factor: 28.547

3.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

Authors:  John Rush; Albrecht Moritz; Kimberly A Lee; Ailan Guo; Valerie L Goss; Erik J Spek; Hui Zhang; Xiang-Ming Zha; Roberto D Polakiewicz; Michael J Comb
Journal:  Nat Biotechnol       Date:  2004-12-12       Impact factor: 54.908

4.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

5.  Fragmentation of phosphopeptides in an ion trap mass spectrometer.

Authors:  J P DeGnore; J Qin
Journal:  J Am Soc Mass Spectrom       Date:  1998-11       Impact factor: 3.109

6.  Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.

Authors:  Thomas Fath; Jochen Eidenmüller; Roland Brandt
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

7.  Direct analysis of protein complexes using mass spectrometry.

Authors:  A J Link; J Eng; D M Schieltz; E Carmack; G J Mize; D R Morris; B M Garvik; J R Yates
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

8.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

Review 9.  Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration.

Authors:  D Allan Butterfield; Debra Boyd-Kimball; Alessandra Castegna
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

Review 10.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

View more
  44 in total

1.  Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Eugenio Barone; Marzia Perluigi; Chiara Cini; Cesare Mancuso; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

2.  Splice-specific glycine receptor binding, folding, and phosphorylation of the scaffolding protein gephyrin.

Authors:  Jens Herweg; Guenter Schwarz
Journal:  J Biol Chem       Date:  2012-02-17       Impact factor: 5.157

3.  U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.

Authors:  Bing Bai; Chadwick M Hales; Ping-Chung Chen; Yair Gozal; Eric B Dammer; Jason J Fritz; Xusheng Wang; Qiangwei Xia; Duc M Duong; Craig Street; Gloria Cantero; Dongmei Cheng; Drew R Jones; Zhiping Wu; Yuxin Li; Ian Diner; Craig J Heilman; Howard D Rees; Hao Wu; Li Lin; Keith E Szulwach; Marla Gearing; Elliott J Mufson; David A Bennett; Thomas J Montine; Nicholas T Seyfried; Thomas S Wingo; Yi E Sun; Peng Jin; John Hanfelt; Donna M Willcock; Allan Levey; James J Lah; Junmin Peng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-10       Impact factor: 11.205

4.  Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease.

Authors:  Laura E Donovan; Lenora Higginbotham; Eric B Dammer; Marla Gearing; Howard D Rees; Qiangwei Xia; Duc M Duong; Nicholas T Seyfried; James J Lah; Allan I Levey
Journal:  Proteomics Clin Appl       Date:  2012-04       Impact factor: 3.494

5.  Online nanoflow multidimensional fractionation for high efficiency phosphopeptide analysis.

Authors:  Scott B Ficarro; Yi Zhang; Marlene J Carrasco-Alfonso; Brijesh Garg; Guillaume Adelmant; James T Webber; C John Luckey; Jarrod A Marto
Journal:  Mol Cell Proteomics       Date:  2011-07-25       Impact factor: 5.911

6.  Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins.

Authors:  Eric B Dammer; Andrew K Lee; Duc M Duong; Marla Gearing; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 7.  Quantitative proteomic analysis of histone modifications.

Authors:  He Huang; Shu Lin; Benjamin A Garcia; Yingming Zhao
Journal:  Chem Rev       Date:  2015-02-17       Impact factor: 60.622

Review 8.  Proteomic Analysis of Postsynaptic Protein Complexes Underlying Neuronal Plasticity.

Authors:  Anthony J Baucum
Journal:  ACS Chem Neurosci       Date:  2017-02-23       Impact factor: 4.418

Review 9.  Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?

Authors:  Guillermo Moya-Alvarado; Noga Gershoni-Emek; Eran Perlson; Francisca C Bronfman
Journal:  Mol Cell Proteomics       Date:  2015-12-11       Impact factor: 5.911

10.  In vivo phosphoproteome of human skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS.

Authors:  Kurt Højlund; Benjamin P Bowen; Hyonson Hwang; Charles R Flynn; Lohith Madireddy; Thangiah Geetha; Paul Langlais; Christian Meyer; Lawrence J Mandarino; Zhengping Yi
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.